Modular Medical (MODD) Pairing Technology Issued New U.S. Patent
https://www.zacks.com/stock/news/2221156/modular-medical-modd-pairing-technology-issued-new-u-s-patent?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2221156
Feb 05, 2024 - Modular Medical's (MODD) latest U.S. patent is likely to protect the company's technology addressing pairing and allow clinicians to easily upload and review patients' data.
0
Philips' (PHG) New Innovation to Enhance Cardiovascular Imaging
https://www.zacks.com/stock/news/2220343/philips-phg-new-innovation-to-enhance-cardiovascular-imaging?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2220343
Feb 02, 2024 - Philips' (PHG) latest X11-4t Mini 3D TEE transducer is likely to have an edge over the traditional 3D TEE in terms of catering to a broader range of patients and improved overall comfort.
0
Labcorp (LH) Unveils Test for Preeclampsia in Pregnant Women
https://www.zacks.com/stock/news/2219761/labcorp-lh-unveils-test-for-preeclampsia-in-pregnant-women?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2219761
Feb 01, 2024 - Labcorp (LH) test System, which is available through clinicians, is the first FDA-cleared biomarker test to aid in the risk assessment of progression to severe preeclampsia.
0
Cardinal Health (CAH) Beats on Q2 Earnings, Ups '24 EPS View
https://www.zacks.com/stock/news/2219544/cardinal-health-cah-beats-on-q2-earnings-ups-24-eps-view?cid=CS-ZC-FT-analyst_blog|earnings_article-2219544
Feb 01, 2024 - Cardinal Health's (CAH) second-quarter fiscal 2024 results benefit from the Pharmaceutical segment's solid performance.
0
BD's (BDX) Tie-Up to Offer AI-Based Digital System for Pap Test
https://www.zacks.com/stock/news/2218936/bd-s-bdx-tie-up-to-offer-ai-based-digital-system-for-pap-test?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2218936
Jan 31, 2024 - BD's (BDX) latest partnership is likely to aid cytotechnologists and pathologists to efficiently identify evidence of cervical cancer and pre-cancerous lesions.
0
Here's Why You Should Retain Hologic (HOLX) Stock for Now
https://www.zacks.com/stock/news/2218881/here-s-why-you-should-retain-hologic-holx-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2218881
Jan 31, 2024 - Investors are optimistic about Hologic (HOLX) owing to its strength in the Breast Health and GYN Surgical segments.
0
Cencora (COR) Beats on Q1 Earnings & Revenues, Ups 2024 Outlook
https://www.zacks.com/stock/news/2218833/cencora-cor-beats-on-q1-earnings-revenues-ups-2024-outlook?cid=CS-ZC-FT-analyst_blog|earnings_article-2218833
Jan 31, 2024 - Cencora's (COR) first-quarter fiscal 2024 results benefit from overall market growth, including rising demand for GLP-1 drugs and COVID-19 vaccines. Inflationary pressure remains.
0
Here's Why You Should Retain Neogen (NEOG) Stock for Now
https://www.zacks.com/stock/news/2218223/here-s-why-you-should-retain-neogen-neog-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2218223
Jan 30, 2024 - Investors are optimistic about Neogen (NEOG) on strong growth in Animal and Food Safety businesses.
0
Bruker (BRKR) to Advance in Lab Automation With New Buyout
https://www.zacks.com/stock/news/2217266/bruker-brkr-to-advance-in-lab-automation-with-new-buyout?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2217266
Jan 29, 2024 - This strategic move positions Bruker (BRKR) to further strengthen its Project Accelerate 2.0 initiative, focusing on "Assays, Software, and Aftermarket."
0
AngioDynamics' (ANGO) New XL Catheter to Help in PAD Treatment
https://www.zacks.com/stock/news/2215940/angiodynamics-ango-new-xl-catheter-to-help-in-pad-treatment?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2215940
Jan 25, 2024 - AngioDymics' (ANGO) new FDA-approved Auryon XL Catheter is likely to boost PAD treatment by eliminating access site complications in Atherectomy procedures.
0